EMD-11119
Structure of the prefusion SARS-CoV-2 spike glycoprotein
EMD-11119
Single-particle3.4 Å
Deposition: 03/06/2020Map released: 01/07/2020
Last modified: 09/07/2025
Sample Organism:
Enterobacteria phage T4
Sample: SARS-CoV-2 spike glycoprotein
Fitted models: 6z97
Deposition Authors: Duyvesteyn HME
,
Ren J
Sample: SARS-CoV-2 spike glycoprotein
Fitted models: 6z97
Deposition Authors: Duyvesteyn HME
,
Ren J
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike.
Huo J,
Zhao Y ,
Ren J ,
Zhou D ,
Duyvesteyn HME ,
Ginn HM,
Carrique L ,
Malinauskas T ,
Ruza RR ,
Shah PNM ,
Tan TK ,
Rijal P,
Coombes N ,
Bewley KR ,
Tree JA ,
Radecke J,
Paterson NG ,
Supasa P,
Mongkolsapaya J,
Screaton GR ,
Carroll M,
Townsend A,
Fry EE,
Owens RJ ,
Stuart DI
(2020) Cell Host Microbe , 28 , 445 - 454.e6
,
Ren J ,
Zhou D ,
Duyvesteyn HME ,
Ginn HM,
Carrique L ,
Malinauskas T ,
Ruza RR ,
Shah PNM ,
Tan TK ,
Rijal P,
Coombes N ,
Bewley KR ,
Tree JA ,
Radecke J,
Paterson NG ,
Supasa P,
Mongkolsapaya J,
Screaton GR ,
Carroll M,
Townsend A,
Fry EE,
Owens RJ ,
Stuart DI
(2020) Cell Host Microbe , 28 , 445 - 454.e6
Grant Support:
- Medical Research Council (MRC, United Kingdom): MR/N00065X/1 (United Kingdom)
- Wellcome Trust: 101122/Z/13/Z (United Kingdom)
- CAMS Innovation Fund for Medical Sciences (CIFMS): 2018-I2M-2-002 (China)